	Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancer. Urol Oncol Sharifi SHH, Ryan JT, Williams A, Tapia-Stoll N, Bitaraf M, Abdshah A, Soodana-Prakash N, Khandekar A, Swain S, Kryvenko ON, Stoyanova R, Pollack A, Castillo PR, Nahar B, Ritch CR, Kava B, Gonzalgo ML, Parekh DJ, Punnen S. PMID: 41956940 [PubMed - as supplied by publisher]
	Associations Between Quality of Life and Disease Progression in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials. Eur Urol Oncol Morgans AK, Ekberg S, Boegemann M, Paracha N, Gallagher E, Gasparini A, Crowther MJ, Shore N, Wallis CJD. PMID: 41956912 [PubMed - as supplied by publisher]
	Re: Chase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al. Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic Pathway. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.10.015. Eur Urol Kadam A, Misra A, Prakash G. PMID: 41956860 [PubMed - as supplied by publisher]
	Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study. J Immunother Cancer Perez-Gracia JL, Mellado B, Hansen AR, Alonso-Gordoa T, Gomez-Roca C, Løvendahl Eefsen R, Negrier S, Suárez C, Lee JL, Hussain A, Pedrazzoli P, Moreno V, Rodriguez-Vida A, Sosman JA, Waddell T, Bedke J, Park SH, Sznol M, Spychaj L, Andersson E, Julien-Laferriere A, Cheng WY, Watson C, Silva AP, Heichinger C, Staedler N, Sleiman N, Dejardin D, Boetsch C, Evers S, Vardar T, Ardeshir-Tandon C, Dorado Pérez J, Charo J, Keshelava N, Kraxner A, Teichgräber V, Powles T. PMID: 41956546 [PubMed - indexed for MEDLINE]
	DNA repair RAD 18 rs373572 and OGG1 rs1052133 genes polymorphisms association with histological characterization of renal cell carcinoma. Wiad Lek Altemimi IKA, Ameen BAM, Al-Terehi MN, Hussein LM. PMID: 41955591 [PubMed - indexed for MEDLINE]
	Expression of lncRNA-ATB and miR-200c in patients with bladder cancer: a pilot study. Lab Med Kaytaz M, Degirmenci ME, Kucukgergin C, Aydin AF, Sanli O, Erdem S, Ozcan F, Ozluk Y, Dogru Abbasoglu S. PMID: 41955422 [PubMed - indexed for MEDLINE]
	Renal Oncocytic Neoplasms: Review of Classification Updates, Imaging, and Management. Radiographics Akobeng MA, Bhayana R, Di Loreto M, Taffel M, Woo S, Tirumani SH, Shanbhogue K, Prendeville S, Elsayes K, Schieda N, Silverman SG, Krishna S. PMID: 41955128 [PubMed - indexed for MEDLINE]
	Screening policy changes and prostate cancer epidemiology: 20-year trends in diagnosis, treatment, incidence, and mortality. World J Urol Jin S, Xia K, Wang J, Zhang H, Ye YN. PMID: 41954768 [PubMed - indexed for MEDLINE]
	Renal medullary carcinoma: a systematic review of clinical and radiological findings. Int Urol Nephrol Weston W, Sit C, Dafydd DA, Kelly-Morland C, Sohaib A, Adamane S, Manickavasagar T, Pickering L, Nicol D, Withey SJ. PMID: 41954690 [PubMed - as supplied by publisher]
	The Proposed Introduction of a Prostate Cancer Screening Program in Germany: Procedure, Necessary Studies before Implementation, Benefits, and Risks. Dtsch Arztebl Int Albers P, Carlsson S, Krilaviciute A, Seibold P, Becker N. PMID: 41954430 [PubMed - as supplied by publisher]
	Safety, Feasibility and Prognostic Analysis of Surgical Treatment for High-Complexity Renal Tumours (RENAL ScoreÂ â‰¥Â 10): A Summary of Experience With Robotic Technology Applications. Int J Med Robot Xu L, Wang J, Shi Y, Sun G, Zeng H. PMID: 41954116 [PubMed - indexed for MEDLINE]
	Association of EBV infection with increased cancer aggressiveness in prostate cancer patients: A systematic review and meta-analysis. Adv Clin Exp Med Abidi SH, Fabiyi OT, Omarova Z, Sheikh A, Ahmed K, Bajpai R. PMID: 41953983 [PubMed - as supplied by publisher]
	Neoadjuvant Toripalimab Plus Axitinib for Nonmetastatic Clear Cell Renal Cell Carcinoma With Tumor Thrombus: A Combined Analysis of Two Phase II Clinical Trials. MedComm (2020) Peng C, Wu Z, Wang Y, Liang Q, Wang D, Zhao H, Li J, Yue X, Zhang Y, Song J, Shi C, Wang H, Yang G, Wang B, Huang Q, Zhang X, Ma X, Huang J, Gu L. PMID: 41953639 [PubMed]
	Efficacy and safety of antibody-drug conjugate based therapy in locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis of emerging clinical evidence. Front Immunol Dai Y, Xiao C, Wang L, Zhou W, Bo R, Cheng Z, Pan G. PMID: 41953009 [PubMed - indexed for MEDLINE]
	Identification of biomarkers for non-invasive diagnosis and risk stratification in prostate cancer using NMR-based metabolomics and machine learning. NPJ Precis Oncol Zhang X, Chen M, Xia B, Liu B, Lin X, Tao H, Wang H, Gu T, Li J, Dong B, Gao H. PMID: 41951831 [PubMed - as supplied by publisher]
	Novel Theranostic Targets for Prostate Cancer Beyond Prostate-Specific Membrane Antigen. PET Clin Heidari P, Jadvar H, Kako B, Esfahani SA. PMID: 41951504 [PubMed - as supplied by publisher]
	Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer - Current State and Evolving Standards. PET Clin Satapathy S, Chandekar KR, Damle NA. PMID: 41951503 [PubMed - as supplied by publisher]
	[Image-Guided Irreversible Electroporation for the Treatment of Localized Prostate Cancer]. Aktuelle Urol Collettini F, Auer TA, Stephan C, Fischer T, Gebauer B. PMID: 41950915 [PubMed - indexed for MEDLINE]
	Integrative analysis of urinary microRNAs for prostate cancer detection: A proof-of-concept study. Transl Oncol Samani LA, Rahmani S, Kashi AH, Ziaee SAM, Mowla SJ. PMID: 41950670 [PubMed - as supplied by publisher]
	Incidental Detection of Glioblastoma Multiforme With PSMA Uptake on Initial Prostate Cancer Staging. Clin Nucl Med Ahmadi M, Tanha AS, Elahifard H, Bahonar M, Askari E. PMID: 41950268 [PubMed - as supplied by publisher]

Articles 1 - 20 / 177369

Page 1 of 8869



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy